A Natural Approach to Regenerative
Early in life, the body develops as a result of embryonic stem cells changing into diﬀerent types of cells. However, in adulthood, we have mesenchymal stem cells which are traditionally found in bone marrow and fat. In the medical field, we have discovered that these non-specified mesenchymal stem cells can repair damaged cells in the event of injury or cellular damage.
The body’s mesenchymal stem cells typically replace the skin every two weeks, creating new red and white blood cells all while helping the body perform other essential tasks. In short, stem cells can:
- Self-renew, or divide into another stem cell (by making a copy of itself)
- Diﬀerentiate, or change into another cell type
Because of this, they can help create new and healthy cells. This healing process is highly beneficial for a wide range of conditions. By concentrating stem cells in the targeted area, doctors can accelerate tissue repair and overall healing.
The market for Growth Factors is currently growing at a rate of approximately 36% per year.
The applications for Growth Factors are expansive. Growth Factors may be useful for conditions such as:
- Memory loss
- Autoimmune conditions
- Elbow and knee pain
- Musculoskeletal and sports injuries
- Vision problems
Recent research has also suggested that Growth Factors can rejuvenate “old hearts” by replacing them with new ones (and therefore strengthening the tissues of the heart).
According to these studies, stem therapy resulted in:
- Increased functionality of the heart
- Enhanced stamina for exercise (upwards of 20% improvement)
- Longer telomeres for heart cells
Can Growth Factors Slow the Aging Process?
Research indicates that Growth Factors can in fact slow or reverse aging.
Specifically, Growth Factors can repair and renew brain cells called neurons. This includes the hypothalamus, which oversees the hormones that control aging.
In addition, Growth Factors can slow the aging process by helping to treat or prevent conditions like osteoarthritis and multiple sclerosis.
Osteoarthritis is an autoimmune and degenerative disease that aﬀects the joints. The knees are especially aﬀected, and in knee osteoarthritis specifically, the cartilage between the knee joints tends to wear oﬀ.
Since cartilage is slow to regenerate in most cases, the joint may lose its functionality. Growth Factors, however, can give the aﬀected knees an appropriate amount of stem cells so the cartilage can repair itself.
And now multiple sclerosis—studies completed on mice reveal that Growth Factors can improve mobility by healing the neurons. These clinical trials are giving scientists ground to apply their results to humans and work toward treating other neurodegenerative diseases using Growth Factors.
LIVE CELL DISCLAIMER
Live cells currently could be used only in an autologous fashion (the patient is the donor as well as the recipient), and while there is enormous promise in live-cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.
The FDA has stated:
live cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any live cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood-forming live cells) for certain indications. http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194655.htm
This site is not for purpose of diagnosis and treatment. The cases discussed in this website are not typical. If you are considering live cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the live cells are your own.
If you are considering having live cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a live cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate live cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their live-cell products. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm286155.htm
Live cell therapies have enormous promise, but the science in each use is still in the developmental stage. Professional judgment and expertise are needed in using live cells for any therapeutic use, and we urge anyone embarking on the use of live-cell therapies to consult the national health databases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.